An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Clinical trial NCT02400476 · COMPLETED
Trial details
- NCT number
- NCT02400476
- Sponsor
- Puma Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2021-04-22
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.